Clinical and dosimetric factors of radiation-induced esophageal injury: Radiation-induced esophageal toxicity

World Journal of Gastroenterology

Volumn 11, Issue 17, 2005, Pages 2626-2629

  Qiao, Wen Bo ^a   Zhao, Yan Hui ^a   Zhao, Yan Bin ^a   Wang, Rui Zhi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

3D CRT; Chemotherapy; Esophagitis; Non small cell lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; NAVELBINE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CAUSE OF DEATH; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE CALCULATION; DOSIMETRY; ESOPHAGUS INJURY; ESOPHAGUS PERFORATION; FEMALE; FOLLOW UP; HUMAN; LUNG BIOPSY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MAXIMUM PERMISSIBLE DOSE; RADIATION DOSE; RADIATION INJURY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

EID: 18944404259     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i17.2626     Document Type: Article

References (16)

1. Bradley JD, Ieumwananonthachai N, Purdy JA, Wasserman TH, Locktt MA, Graham MV, Perez CA. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therpy for non-small-cell-lung carcinoma. Int J Radiat Oncol Biol Phys 2002; 52: 49-57
2. Northway MG, Libshitz HI, West JJ, Withers HR, Mukhopadhyay AK, Osborne BM, Szwarc IA, Dodd GD. The opossum an animal model for studying radiation esophagitis. Radiology 1979; 131: 731-735
3. Lepke RA, Libshitz HI. Radiation-induced injury of the esophagus. Radiology 1983; 148: 375-378
4. Choy H, Akerley W, Safran H, Graziano S, Chung C, Williams T, Cole B, Kennedy T. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell cancer. J Clin Oncol 1998; 16: 3316-3322
5. Werner-Wasik M, Scott C, Graham ML, Smith C, Byhardt RW, Roach III M, Andras EJ. Interfraction interval dose not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: A multivariate analysis of 1076 RTOG patients. Int J Radiat Oncol Biol Phys 1999; 44: 327-331
6. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21: 109-122
7. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, Carey RW, Frei EF 3rd, Green MR. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in Stage III non-small cell lung cancer. N Engl J Med 1990; 323: 940-945
8. Maguire PD, Sibley GS, Zhon SM, Jamieson TA, Light KL, Antoine PA, Herndon JE 2nd, Anscher MS, Marks LB. Clicinal and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 1999; 45: 97-103
9. Patel AB, Edelman MJ, Kwok Y, Kreasna MJ, Suntharalingam M. Predictors of acute esophagitis in patients with non-small cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2004; 60: 1106-1112
10. Werner-Wasik M, Pequignot E, Leeper D, Hauck W, Curran WJR. Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of the irradiated esophagus; A multivariate analysis of patients with lung cancer treated with non-operative therapy. Int J Radiat Oncol Biol Phys 2000; 48: 689-696
11. Umsawasdi T, Valdivieso M, Barkley HT, Booser DJ, Chiuten DF, Murphy WK, Dhingra HM, Dixon CL, Farha P, Spitzer G, Carr DT. Esophageal complications from combined chemoradiotherapy (cyclophosphamied+adriamycin+ cisplatin+XRT) in the treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1985; 11: 511-519
12. Kiura K, Ueoka H, Segawa Y, Tabata M, Kakigawa H, Hiraki S, Watanabe Y, Bessho A, Eguchi K, Okimoto N, Harita S, Takemoto M, Hiraki Y, Harada M, Tanimoto M. Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advancednon-small-cell lung cancer. British J Cancer 2003; 89: 795-802
13. Singh AK, Lockett MA, Bradley JD. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three- dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003; 55: 337-341
14. Marks LB, Munley MT, Spencer DP, Sherouse GW, Bentel GC, Hoppenworth J, Chew M, Jaszczak RJ, Coleman RE, Proshitz LR. Quantification of radiation-induced regional lung with perfusion imaging. Int J Radiat Oncol Biol Phys 1997; 38: 399-409
15. Yoshizawa H, Tanaka J, Kagamu H, Maruyama Y, Miyao H, Ito K, Iwashima A, Suzuki E, Gejyo F. Phase I/II study of daily carboplatin, 5-fluorouracil and concurrent radiation therapy for locally advanced non-small cell lung cancer. Br J Cancer 2003; 89: 803-807
16. Antonadou D, Coliarakis N, Synodinou M, Athanassiou H, Kouveli A, Verigos C, Georgakopoulos G, Panoussaki K, Karageorgis P, Throuvalas N. Randomized phase III trial of radiation treatment±amifostine in patients with advanced stage lung cancer. Int J Radiat Oncol Biol Phys 2001; 51: 915-922